Effect of Exercise on Muscle Proteome Signature

January 12, 2021 updated by: Morten Hostrup, PhD

Effect of Exercise Training on Skeletal Muscle Proteome Signature of Young Men

The aim of the study is to investigate skeletal muscle proteome signature changes induced by exercise training in young men

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Advances in omics technologies have allowed for the identification of biomarkers with importance for the beneficial adaptations imposed by exercise training. Skeletal muscle exhibits remarkable plasticity to exercise training, as illustrated by pronounced alterations to the proteomic landscape, such as mitochondrial biogenesis. However, despite recent advances that have helped describe the proteomic landscape in response to a period of exercise training, our understanding of the processes pertaining to post-translation modification is scant. In this study, we aim to investigate the human acetylome and proteome in response to exercise training.

Study Type

Interventional

Enrollment (Actual)

8

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Copenhagen, Denmark, 2100
        • Department of Nutrition, Exercise and Sports

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Healthy
  • VO2max of 45-55 ml/kg/min (+/- SD) / 3000-4000 ml/min (+/- SD)
  • Body mass index (BMI) of 19-26 kg/m2
  • Normal ECG (electrocardiography)

Exclusion Criteria:

  • Serious adverse effects to exercise
  • Chronic disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exercise
12-15 training sessions of 30 min over 4-5 weeks
subjects complete 4-5 weeks of training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Skeletal muscle proteome signature
Time Frame: Change from baseline proteome signature at 5 weeks
proteomics
Change from baseline proteome signature at 5 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Skeletal muscle acetylome signature
Time Frame: Change from baseline acetylome signature at 5 weeks
acetylomics
Change from baseline acetylome signature at 5 weeks
Skeletal muscle mitochondrial respiration
Time Frame: Change from baseline at 5 weeks
Mitochondrial respiratory capacity
Change from baseline at 5 weeks
Maximal oxygen uptake
Time Frame: Change from baseline at 5 weeks
Maximal oxygen uptake
Change from baseline at 5 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 28, 2017

Primary Completion (Actual)

October 15, 2017

Study Completion (Actual)

October 15, 2017

Study Registration Dates

First Submitted

August 28, 2017

First Submitted That Met QC Criteria

August 29, 2017

First Posted (Actual)

September 1, 2017

Study Record Updates

Last Update Posted (Actual)

January 15, 2021

Last Update Submitted That Met QC Criteria

January 12, 2021

Last Verified

January 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • ACE

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on exercise training

3
Subscribe